We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
Cap. Flow
-$3.75B
Cap. Flow %
-69.25%
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
0.5 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.5 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Sector Composition

Rank Sector Weight
1 Financials 25.7%
2 Technology 18.31%
3 Healthcare 15.11%
4 Miscellaneous 11.75%
5 Real Estate 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UMH icon
801
UMH Properties
UMH
$1.3B
– –
-226,207
Closed -$3.65M –
USO icon
802
United States Oil Fund
USO
$1.9B
– –
-67,000
Closed -$4.37M –
VAC icon
803
Marriott Vacations Worldwide
VAC
$3.62B
– –
-13,853
Closed -$1.69M –
VICI icon
804
VICI Properties
VICI
$25.2B
– –
-48,605
Closed -$1.56M –
VLO icon
805
Valero Energy
VLO
$125B
– –
-19,053
Closed -$2.04M –
VMC icon
806
Vulcan Materials
VMC
$31.7B
– –
-18,083
Closed -$2.85M –
VTR icon
807
Ventas
VTR
$42.1B
– –
-88,499
Closed -$3.56M –
W icon
808
Wayfair
W
$14.5B
– –
-29,500
Closed -$960K –
WCN icon
809
Waste Connections
WCN
$38.4B
– –
-18,200
Closed -$2.46M –
WM icon
810
Waste Management
WM
$83.5B
– –
-35,201
Closed -$5.64M –
XBI icon
811
State Street SPDR S&P Biotech ETF
XBI
$10.2B
– –
-50,000
Closed -$3.97M –
XLF icon
812
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.9B
– –
-1,200,000
Closed -$2.21M –
XOM icon
813
ExxonMobil
XOM
$695B
– –
-9,500
Closed -$829K –
XYL icon
814
Xylem
XYL
$24B
– –
-6,155
Closed -$538K –
YMAB icon
815
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-44,000
Closed -$634K –
ZLAB icon
816
Zai Lab
ZLAB
$2.81B
– –
-15,700
Closed -$537K –
ZNTL icon
817
Zentalis Pharmaceuticals
ZNTL
$250M
– –
-13,527
Closed -$293K –
CERO icon
818
DELISTED
CERo Therapeutics
CERO
– –
-95
Closed -$1.93M –
SOC icon
819
Sable Offshore Corp
SOC
$714M
– –
-143,174
Closed -$1.41M –
GTI icon
820
DELISTED
Graphjet Technology
GTI
– –
-3,977
Closed -$2.42M –
TXNM icon
821
TXNM Energy Inc
TXNM
$6.45B
– –
-46,872
Closed -$2.14M –
EXE icon
822
Expand Energy Corp
EXE
$20.4B
– –
-15,275
Closed -$1.44M –
GATE icon
823
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
– –
-476,606
Closed -$4.75M –
JWSM icon
824
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
– –
-506,141
Closed -$5.03M –
AAGR
825
DELISTED
African Agriculture Holdings Inc
AAGR
– –
-166,440
Closed -$1.19M –

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.

  • UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
  • UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
  • UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.